AAAAAA

   
Results: 1-15 |
Results: 15
AUTOFLUORESCENCE BRONCHOSCOPY IN THE DETECTION OF SQUAMOUS METAPLASIAAND DYSPLASIA IN CURRENT AND FORMER SMOKERS
Authors: KURIE JM LEE JS MORICE RC WALSH GL KHURI FR BROXSON A RO JY FRANKLIN WA YU R HONG WK
Citation: Jm. Kurie et al., AUTOFLUORESCENCE BRONCHOSCOPY IN THE DETECTION OF SQUAMOUS METAPLASIAAND DYSPLASIA IN CURRENT AND FORMER SMOKERS, Journal of the National Cancer Institute, 90(13), 1998, pp. 991-995
PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/
Authors: KHURI FR FOSSELLA FV LEE JS MURPHY WK SHIN DM MARKOWITZ AB GLISSON BS
Citation: Fr. Khuri et al., PHASE-II TRIAL OF RECOMBINANT IFN-ALPHA-2A WITH ETOPOSIDE CISPLATIN INDUCTION AND INTERFERON/MEGESTROL ACETATE MAINTENANCE IN EXTENSIVE SMALL-CELL LUNG-CANCER/, Journal of interferon & cytokine research, 18(4), 1998, pp. 241-245
ANTITUMOR-ACTIVITY OF A LIPOSOME-ENTRAPPED CISPLATIN ANALOG (L-NDDP) ADMINISTERED INTRAPLEURALLY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM)
Authors: SHIN DM WALSH GL SWISHER S WIMBERLY A SHIN HJC RO JY KHURI FR LEE JS HONG WK KHOKHAR AR PEREZSOLER R
Citation: Dm. Shin et al., ANTITUMOR-ACTIVITY OF A LIPOSOME-ENTRAPPED CISPLATIN ANALOG (L-NDDP) ADMINISTERED INTRAPLEURALLY IN PATIENTS WITH MALIGNANT PLEURAL MESOTHELIOMA (MPM), Annals of oncology, 9, 1998, pp. 659-659
THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/
Authors: LEE JS PISTERS KMW KOMAKI R GLISSON BS PEREZSOLER R KHURI FR DELCLOS ME FOSSELLA FV
Citation: Js. Lee et al., THE ROLE OF PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS A PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER/, Annals of oncology, 9, 1998, pp. 660-660
PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA
Authors: SHIN DM GLISSON BS KHURI FR GINSBERG L PAPADIMITRAKOPOULOU V LEE JJ LAWHORN K GILLENWATER AM ANG KK CLAYMAN GL CALLENDER DL HONG WK LIPPMAN SM
Citation: Dm. Shin et al., PHASE-II TRIAL OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT HEAD AND NECK SQUAMOUS-CELL CARCINOMA, Journal of clinical oncology, 16(4), 1998, pp. 1325-1330
ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: SHIN DM GLISSON BS KHURI FR HONG WK LIPPMAN SM
Citation: Dm. Shin et al., ROLE OF PACLITAXEL, IFOSFAMIDE, AND CISPLATIN IN PATIENTS WITH RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Seminars in oncology, 25(2), 1998, pp. 40-44
LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER
Authors: ROTH JA SWISHER SG LAWRENCE DD KEMP BL CARRASCO CH ELNAGGAR AK FOSSELA FV GLISSON BS HONG WK KHURI FR KURIE JM NESBITT JC PISTERS K PUTNAM JB SCHRUMP DS SHIN DM WALSH GL
Citation: Ja. Roth et al., LOCAL AND SYSTEMIC STRATEGIES FOR GENE REPLACEMENT FOR CANCER, British Journal of Cancer, 78(2), 1998, pp. 142-142
MOLECULAR EPIDEMIOLOGY AND RETINOID CHEMOPREVENTION OF HEAD AND NECK-CANCER
Authors: KHURI FR LIPPMAN SM SPITZ MR LOTAN R HONG WK
Citation: Fr. Khuri et al., MOLECULAR EPIDEMIOLOGY AND RETINOID CHEMOPREVENTION OF HEAD AND NECK-CANCER, Journal of the National Cancer Institute, 89(3), 1997, pp. 199-211
CLONAL GENETIC ALTERATIONS IN THE LUNGS OF CURRENT AND FORMER SMOKERS
Authors: MAO L LEE JS KURIE JM FAN YH LIPPMAN SM LEE JJ RO JY BROXSON A YU R MORICE RC KEMP BL KHURI FR WALSH GL HITTELMAN WN HONG WK
Citation: L. Mao et al., CLONAL GENETIC ALTERATIONS IN THE LUNGS OF CURRENT AND FORMER SMOKERS, Journal of the National Cancer Institute, 89(12), 1997, pp. 857-862
CORRELATES OF MUTAGEN SENSITIVITY IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CANCER
Authors: SPITZ MR MCPHERSON RS JIANG H HSU TC TRIZNA Z LEE JJ LIPPMAN SM KHURI FR STEFFENBATEY L CHAMBERLAIN RM SCHANTZ SP HONG WK
Citation: Mr. Spitz et al., CORRELATES OF MUTAGEN SENSITIVITY IN PATIENTS WITH UPPER AERODIGESTIVE TRACT CANCER, Cancer epidemiology, biomarkers & prevention, 6(9), 1997, pp. 687-692
CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER
Authors: KHURI FR KURIE JM HONG WK
Citation: Fr. Khuri et al., CHEMOPREVENTION OF RESPIRATORY-TRACT CANCER, Hematology/oncology clinics of North America, 11(3), 1997, pp. 387
RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK
Authors: SHIN DM GLISSON BS KHURI FR GINSBERG L LAWHORN K HONG WK LIPPMAN SM
Citation: Dm. Shin et al., RECENT ADVANCES IN PACILITAXEL-CONTAINING CHEMOTHERAPY FOR RECURRENT OR METASTATIC SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK, Seminars in oncology, 24(6), 1997, pp. 33-37
PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/
Authors: LEE JS PISTERS KMW KOMAKI R GLISSON BS KHURI FR SCHEA R FOSSELLA FV
Citation: Js. Lee et al., PACLITAXEL CARBOPLATIN CHEMOTHERAPY AS PRIMARY-TREATMENT OF BRAIN METASTASES IN NONSMALL CELL LUNG-CANCER - A PRELIMINARY-REPORT/, Seminars in oncology, 24(4), 1997, pp. 52-55
NEW DIRECTIONS IN LUNG-CANCER - CHEMOPREVENTION
Authors: KHURI FR HONG WK LEE JS
Citation: Fr. Khuri et al., NEW DIRECTIONS IN LUNG-CANCER - CHEMOPREVENTION, Seminars in respiratory and critical care medicine, 17(4), 1996, pp. 323-334
RETINOIC ACID-INDUCED TRANSITION FROM PROTEIN-KINASE C-BETA TO PROTEIN-KINASE C-ALPHA IN DIFFERENTIATED F9 CELLS - CORRELATION WITH ALTEREDREGULATION OF PROTOONCOGENE EXPRESSION BY PHORBOL ESTERS
Authors: KHURI FR CHO YH TALMAGE DA
Citation: Fr. Khuri et al., RETINOIC ACID-INDUCED TRANSITION FROM PROTEIN-KINASE C-BETA TO PROTEIN-KINASE C-ALPHA IN DIFFERENTIATED F9 CELLS - CORRELATION WITH ALTEREDREGULATION OF PROTOONCOGENE EXPRESSION BY PHORBOL ESTERS, Cell growth & differentiation, 7(5), 1996, pp. 595-602
Risultati: 1-15 |